Therabron Therapeutics’s Phase 2a Study on Pediatric Respiratory Health Solution 50% Enrolled
Chronic Bronchitis, News
Therabron Therapeutics, Inc., a biotechnology company that specializes in providing breakthrough solutions to respiratory disease management, recently announced it has already enrolled half of the targeted number of patients in a Phase ... Read more